JNJ Bids $3bn-Plus To Buy Halda, Lead Prostate Cancer Candidate

 
• By Joseph Haas
  
J&J looks to add to its prostate cancer franchise with Halda buyout. (Alaric DeArment/Scrip)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business